Shuang Wei
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 4
- Neurology top 2%
- Oncology top 5%
- Biochemistry top 5%
- Modeling and Simulation top 5%
-
- Cancer-related gene regulation 6
- Epigenetics and DNA Methylation 6
- Advanced biosensing and bioanalysis techniques 4
- RNA modifications and cancer 4
-
- Glioma Diagnosis and Treatment 4
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 4
- Cited by
- Infectious DiseasesNeurologyOncology
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)Advanced Functional Materials (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Shuang Wei
75 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Infectious Diseases 1.1k
- Neurology 638
- Oncology 503
- Biochemistry 115
- Modeling and Simulation 65
Countries citing papers authored by Shuang Wei
This map shows the geographic impact of Shuang Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuang Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuang Wei more than expected).
Fields of papers citing papers by Shuang Wei
This network shows the impact of papers produced by Shuang Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuang Wei. The network helps show where Shuang Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shuang Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 12 | |
| 6 | 2024 | 14 | |
| 7 | 2024 | 16 | |
| 8 | 2023 | 16 | |
| 9 | 2023 | 22 | |
| 10 | 2023 | 10 | |
| 11 | 2023 | 27 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 11 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 12 | |
| 16 | 2021 | 15 | |
| 17 | 2019 | 60 | |
| 18 | 2015 | 6 | |
| 19 | 2012 | 29 | |
| 20 | Research and Design of Dead Message Handling Mechanism in JMS | 2010 | 2 |
About Shuang Wei
Shuang Wei is a scholar working on Filtration and Separation, Cancer Research and Hepatology, having authored 81 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer-related gene regulation (6 papers), Epigenetics and DNA Methylation (6 papers), Glioma Diagnosis and Treatment (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), RNA modifications and cancer (4 papers), SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Neurology (638 citations) and Oncology (503 citations). Shuang Wei has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Huiguo Liu, Kui Liu, Ling Zhou, Wei Liu, Yan Deng, Ming Yang, Lei Wang, Jing Liu, Yi Hu and Miao Luo. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.